Dan Shu
University of Maryland, Baltimore
ORCID: 0000-0002-0267-1102Also affiliated with University of Electronic Science and Technology of China, Chinese Academy of Sciences, The Affiliated Yongchuan Hospital of Chongqing Medical University, BYD (China), Chengdu Institute of Biology, Tongji Hospital, Chemical Pharmaceutical Research Institute, Wuhan University of Science and Technology, Huazhong University of Science and Technology, The Ohio State University, University of Baltimore, Wuhan Sports University, Chongqing Medical University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 11 papers. Top paper: “Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19”.
Namir Shaabani, Xiaoying Zhang, Can Jin, Wanhong Xu, Christopher Argent +36 more
Harshit Shah, Hongzhi Wang, Dan Shu, Steven Y. Qian, Venkatachalem Sathish +1 more
Songchuan Guo, Hongran Yin, Tae Jin Lee, Shujun Liu, Dan Shu +2 more
Long Zhang, Xue‐Feng Bai, Jianhua Yu, Peixuan Guo, Dan Shu
Kenneth M. McCullough, Sergey Naumenko, Andrew Thompson, Claudia Klengel, Allison C. Rodgers +6 more
Daniel W. Binzel, Dan Shu, Tian‐Min Fu, Peixuan Guo, Nasir Uddin
Hongzhi Wang, Wen-Jui Lee, Dan Shu, Peixuan Guo, Satheesh Ellipilli
Hongzhi Wang, Daniel W. Binzel, Dan Shu, Peixuan Guo, Satheesh Ellipilli
Kai Jin, Haizhu Shi, Austen Jones, Dalton Hironaka, Gaofeng Xiong +5 more
Lizhi Pang, Hongzhi Wang, Dan Shu, Steven Y. Qian, Venkatachalem Sathish +1 more
Abhjeet S. Bhullar, Chenxi Liang, Long Zhang, Peixuan Guo, Dan Shu